BUPA risk equalisation demand four times too much, says insurance study
The report by Goodbody Economic Consultants says the €33 million annual demand on BUPA, which prompted the company to announce its withdrawal from Ireland, could have been reduced to as little as €8.3m.
The report was commissioned by VIVAS health which faces making its first annual payment to VHI under the controversial risk equalisation scheme in October this year. Its chief executive Oliver Tattan said yesterday his company expected demands of at least €20m over the next three years.